BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• Business

  Fresenius Medical Care starts the year with strong earnings growth

  Care Enablement delivered strong sequential margin improvement with significant progress towards the 2025 target margin band.

  May 7, 2024

   · 

  13 min read
• Business

  Novanta Announces Financial Results for the First Quarter 2024

  Novanta Inc., a trusted technology partner to medical and advanced technology equipment manufacturers, reported financial results for the first quarter 2024.

  May 7, 2024

   · 

  27 min read
• Biotech Bay

  Bristol Myers Squibb to Participate in Upcoming Investor Conferences in May 2024

  Bristol Myers Squibb announced that the company will participate in two upcoming investor conferences in May 2024.

  May 7, 2024

   · 

  1 min read
• Business

  PureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments

  PureTech Health plc, a clinical-stage biotherapeutics company, noted that its Founded Entity, Seaport Therapeutics, a biopharmaceutical company that is charting a proven path in neuropsychiatry, announced the appointment of Denice Torres, J.D., to its Board of Directors.

  May 7, 2024

   · 

  10 min read
• Business

  Neuronetics Reports Record First Quarter 2024 Financial and Operating Results

  Neuronetics, Inc. a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the best neurohealth therapies in the world, announced its financial and operating results for the first quarter of 2024.

  May 7, 2024

   · 

  15 min read
• BioCapital

  Altimmune to Participate at Two Upcoming May 2024 Investor Conferences

  Altimmune, Inc., a clinical-stage biopharmaceutical company, announced that members of the Company’s management team will participate and be available for 1x1 meetings at the following investor conferences:

  May 7, 2024

   · 

  1 min read
• Policy

  Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19 in Moderately to Severely Immunocompromised People, Based on U.S. FDA Feedback

  Invivyd, Inc. announced its intention to submit an emergency use authorization application to the U.S. Food and Drug Administration for pemivibart for the treatment of mild to moderate symptomatic COVID-19 in certain immunocompromised people utilizing a rapid immunobridging pathway.

  May 7, 2024

   · 

  14 min read
• BioMidwest

  Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 07, 2024

  Abeona Therapeutics Inc. announced it has granted equity awards to new non-executive employees who joined the Company.

  May 7, 2024

   · 

  3 min read
• Drug Development

  ASLAN Pharmaceuticals to Present Additional Data From Interim Analysis of TREK-DX Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual KOL Event

  ASLAN Pharmaceuticals will host a virtual KOL event, during which Company management will present new data from the interim analysis of the Phase 2 TREK-DX study of eblasakimab in dupilumab-experienced atopic dermatitis patients.

  May 7, 2024

   · 

  9 min read
• Genetown

  Verastem Oncology to Present at the RBC Capital Markets Global Healthcare Conference

  Verastem Oncology announced that its management team will participate in a fireside chat at the 2024 RBC Capital Markets Global Healthcare Conference in New York on Tuesday, May 14, 2024 at 3:35 pm EDT.

  May 7, 2024

   · 

  1 min read